Inhibiting surface crystallization of amorphous indomethacin by nanocoating

Langmuir

Volumn 23, Issue 9, 2007, Pages 5148-5153

  Wu, Tian ^a   Sun, Ye ^a   Li, Ning ^a   De Villiers, Melgardt M ^a   Yu, Lian ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETHACIN (IMC); NANOCOATINGS; ORGANIC GLASS; SURFACE CRYSTALLIZATION;

CRYSTALLIZATION; DRUG PRODUCTS; POLYELECTROLYTES; SOLUBILITY; SPUTTERING; ULTRATHIN FILMS;

GLASS;

ELECTROLYTE; GLASS; GOLD; INDOMETACIN; POLY N,N DIMETHYL N,N DIALLYLAMMONIUM CHLORIDE; POLY-N,N-DIMETHYL-N,N-DIALLYLAMMONIUM CHLORIDE; POLYETHYLENE DERIVATIVE; POLYSTYRENE DERIVATIVE; POLYSTYRENESULFONIC ACID; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ADSORPTION; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; SOLUTION AND SOLUBILITY; SURFACE PROPERTY; TIME;

ADSORPTION; CRYSTALLIZATION; ELECTROLYTES; GLASS; GOLD; INDOMETHACIN; MOLECULAR STRUCTURE; NANOTECHNOLOGY; PARTICLE SIZE; POLYETHYLENES; POLYSTYRENES; QUATERNARY AMMONIUM COMPOUNDS; SOLUTIONS; SURFACE PROPERTIES; TIME FACTORS; WATER;

EID: 34248334514     PISSN: 07437463     EISSN: None     Source Type: Journal    
DOI: 10.1021/la070050i     Document Type: Article

References (31)

1. Zallen, R. The Physics of Amorphous Solids; John Wiley & Sons: New York, 1983.
2. Kaushal, A. M.; Gupta, P.; Bansal, A. K. Crit. Rev. Ther. Drug Carrier Syst. 2004, 21, 133-193.
3. Hancock, B. C.; Zografi, G. J. Pharm. Sci. 1997, 86, 1-12.
4. Yu, L. Adv. Drug Delivery Rev. 2001, 48, 27-42.
5. Zanotto, E. D. Ceram. Trans. 1993, 30, 65-74.
6. Diaz-Mora, N.; Zanotto, E. D.; Hergt, R.; Muller, R. J. Non-Cryst. Solids 2000, 273, 81-93.
7. Wittman, E.; Zanotto, E. D. J. Non-Cryst. Solids 2000, 271, 94-99.
8. Wu, T.; Yu, L. Pharm. Res. 2006, 23, 2350-2355.
9. Imaizumi, H.; Nambu, N.; Nagai, T. Chem. Pharm. Bull. 1980, 28, 2565-2569.
10. Yoshioka, M.; Hancock, B. C.; Zografi, G. J. Pharm. Sci. 1994, 83, 1700-5.
11. Wu, T.; Yu, L. J. Phys. Chem. B 2006, 110, 15694-15699.
12. Weber, R.; Zimmermann, K.-M.; Tolan, M.; Stettner, J.; Press, W.; Seeck, O. H.; Erichsen, J.; Zaporojtchenko, V.; Strunskus, T.; Faupel, F. Phys. Rev. E 2001, 64, 061508-1-5.
13. Weber, R.; Grotkopp, I.; Stettner, J.; Tolan, M.; Press, W. Macromolecules 2003, 36, 9100-9106
14. Bell, R. C.; Wang, H.; Iedema, M. J.; Cowin, J. P. J. Am. Chem. Soc. 2003, 125, 5176-5185.
15. Swallen, S.; Kearns, K.; Mapes, M.; McMahon, R.; Kim, S.; Ediger, M.; Yu, L.; Wu, T.; Satija, S. Science 2007, 315, 353-356.
16. Kichert, R.; Yang, M. J. Phys. Chem. B 2003, 107, 895-898.
17. Imaizumi, H.; Nambu, N.; Nagai, T. Chem. Pharm. Bull. 1983, 31, 2510-2512.
18. Crowley, K. J.; Zografi, G. Pharm. Res. 2003, 20, 1417-1422.
19. Lvov, Y.; Decher, G.; Moehwald, H. Langmuir 1993, 9, 481-6.
20. Ai, H.; Jones, S.; de Villiers, M. M.; Lvov, Y. M. J. Controlled Release 2003, 86, 59-68.
21. Pargaonkar, N.; Lvov, Y. M.; Li, N.; Steenekamp, J. H.; de Villiers, M. M. Pharm. Res. 2005, 22, 826-835.
22. Zahr, A. S.; de Villiers, M. M.; Pishko, M. V. Langmuir 2005, 21, 403-410.
23. Shutava, T. G.; Kommireddy, D. S.; Lvov, Y. M. J. Am. Chem. Soc. 2006, 128, 9926-9934.
24. Zheng, Z.; McDonald, J.; Khillan, R.; Su, Y.; Shutava, T.; Grozdits, G.; Lvov, Y. M. J. Nanosci. Nanotechnol. 2006, 6, 624-32.
25. Ye, S.; Wang, C.; Liu, X.; Tong, Z. J. Controlled Release 2005, 106, 319-328.
26. Chen, Y.; Lin, X. J. Microencapsulation 2005, 22, 47-55.
27. Hancock, B. C.; Parks, M. Pharm. Res. 2000, 17, 397-404.
28. Zografi, G.; Tam, S. S. J. Pharm. Sci. 1976, 65, 1145-9.
29. Aulton, M. E. Pharmaceutics: The Science of Dosage Form Design; Churchil Livingstone: London, 2002.
30. Viegas, T. X.; Curatella, R. U.; Van Winkle, L. L.; Brinker, G. Pharm. Technol. North America 2001, 25, 44-53.
31. Mauger, J.; Ballard, J.; Brockson, R.; De, S.; Gray, V.; Robinson, D. Dissolution Technol. 2003, 10, 6-15.